Alyssa George: Anticoagulation Management During the Diagnostic Evaluation of HIT
Alyssa George, Clinical Pharmacist at Henry Ford Health, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
“I’m excited to share that my PGY2 project on anticoagulation management during the diagnostic evaluation of heparin-induced thrombocytopenia (HIT) has been published in the Journal of Thrombosis and Thrombolysis!
Our study examined anticoagulation prescribing practices before and after implementation of an on-demand rapid PF4 immunoassay, replacing a once-daily ELISA PF4 assay for suspected HIT cases.
Following implementation of the rapid assay, significantly fewer patients were transitioned to therapeutic non-heparin anticoagulation, with no difference in new or worsening thrombosis or bleeding events within 72 hours of testing.
I’m incredibly grateful for the opportunity to work alongside such supportive mentors and colleagues throughout this project!”
Title: Evaluation of anticoagulation management in patients with suspected
heparin-induced thrombocytopenia awaiting diagnosis confirmation
Authors: Alyssa R. George, Katelyn W. Sylvester, Dareen M. Kanaan, Delaney M. Brooks, Kenneth E. Lupi, Brian R. Schuler, Jean M. Connors
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis